Related Funds
Funds with similar focus
Fund Name | Location |
BioSTL | Missouri, St Louis, United States |
Carelabs | - |
Glint Consulting | Al Qahirah, Cairo, Egypt |
Hino Motors | Hino, Japan, Shiga Prefecture |
Huayi Lianhe | Beijing, Beijing, China |
Mirova | France, Ile-de-France, Paris |
North Carolina GlaxoSmithKline Foundation | Durham, North Carolina, United States |
Oxford Properties Group | Canada, Ontario, Toronto |
Piedmont Capital Partners | Greensboro, North Carolina, United States |
Sea and Sand Foundation | Canada, Ontario, Toronto |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Elegen | $35M | 14 May 2024 | San Carlos, California, United States | ||
Zafrens | $23M | 11 Dec 2023 | San Diego, California, United States | ||
Chemify | $49M | 02 Aug 2023 | - | ||
Xilis | $19M | 13 Jul 2022 | Durham, North Carolina, United States | ||
Zafrens | $6M | 27 Dec 2021 | San Diego, California, United States | ||
Pair Team | $7M | 07 Dec 2021 | San Francisco, California, United States | ||
Elegen | 01 Dec 2021 | San Carlos, California, United States | |||
Zafrens | 11 Nov 2021 | San Diego, California, United States | |||
Teiko.bio | $11M | 05 Oct 2021 | Salt Lake City, Utah, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Elegen | $35M | 14 May 2024 | San Carlos, California, United States | ||
Zafrens | $23M | 11 Dec 2023 | San Diego, California, United States | ||
Chemify | $49M | 02 Aug 2023 | - | ||
Xilis | $19M | 13 Jul 2022 | Durham, North Carolina, United States | ||
Zafrens | $6M | 27 Dec 2021 | San Diego, California, United States | ||
Pair Team | $7M | 07 Dec 2021 | San Francisco, California, United States | ||
Elegen | 01 Dec 2021 | San Carlos, California, United States | |||
Zafrens | 11 Nov 2021 | San Diego, California, United States | |||
Teiko.bio | $11M | 05 Oct 2021 | Salt Lake City, Utah, United States |